Managing Thrombosis in Cancer Patients

Video

This video reviews recommendations for the prevention and management of thrombosis in patients with cancer.

Cancer patients have a two- to three-fold risk of bleeding compared with the general population.

In this video, Michael Streiff, MD, of Johns Hopkins School of Medicine, discusses recommendations for the prevention and management of thrombosis in patients with cancer.

Streiff also reviews the risks of long-term use of the anticoagulant heparin, including the possibility of an increased of osteoporosis.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
Patients with node-negative disease who are older and have comorbidities may not be suitable to receive CDK4/6 inhibitors.
2 experts in this video
An observed carryover effect with CDK4/6 inhibitors may reduce the risk of recurrence years after a patient stops treatment.
Related Content
3 Intraoperative Radiotherapy: Alive and Well in the Bronx

3 Intraoperative Radiotherapy: Alive and Well in the Bronx

Caroline Oska;Eleni Kohilakis;Jana Fox
July 15th 2025
Article
According to Jorge Nieva, MD, taletrectinib may be a primary frontline therapy option for those with ROS1-positive non–small cell lung cancer.

Taletrectinib Approval Expands Options in Advanced/Metastatic ROS1+ NSCLC

Jorge Nieva, MD
July 14th 2025
Podcast

According to Jorge Nieva, MD, taletrectinib may be a primary frontline therapy option for those with ROS1-positive non–small cell lung cancer.

The confirmed objective response rate among 56 patients with extensive-stage small cell lung cancer was 87.5%, all of whom experienced partial responses.

Frontline LDRT Plus Atezolizumab Combo Shows Efficacy in ES-SCLC

Roman Fabbricatore
July 15th 2025
Article

The confirmed objective response rate among 56 patients with extensive-stage small cell lung cancer was 87.5%, all of whom experienced partial responses.

Best Practices for the Medical Oncology Boards

Best Practices for the Medical Oncology Boards

Eric Singhi, MD;Nicholas James Hornstein, MD, PhD;Marc Braunstein, MD, PhD;Nerea M. Lopetegui-Lia, MD;MinhTri Nguyen, MD
July 7th 2025
Podcast

A group of clinicians gives study advice on how to best prepare for the medical oncology board examinations.

Immunotherapy, Novel Agents May Reshape the Early Breast Cancer Landscape

Immunotherapy, Novel Agents May Reshape the Early Breast Cancer Landscape

Ariana Pelosci
July 15th 2025
Article

Heather McArthur, MD, focused on current and future strategies for treating early-stage breast cancer.

Avutometinib/Defactinib Display Safety, Efficacy in Ovarian Cancer Subtype

Avutometinib/Defactinib Display Safety, Efficacy in Ovarian Cancer Subtype

Roman Fabbricatore
July 14th 2025
Article

Among 115 patients treated with avutometinib and defactinib, only 5 deaths occurred in the study, none of which were related to study treatment.